The closing price of Zoetis Inc (NYSE: ZTS) was $176.23 for the day, down -2.82% from the previous closing price of $181.35. In other words, the price has decreased by -$5.12 from its previous closing price. On the day, 5945136 shares were traded.
Ratios:
Our analysis of ZTS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 39.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 49.78. For the most recent quarter (mrq), Quick Ratio is recorded 2.00 and its Current Ratio is at 3.36. In the meantime, Its Debt-to-Equity ratio is 1.36 whereas as Long-Term Debt/Eq ratio is at 1.35.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Stifel on January 12, 2024, Reiterated its Buy rating but revised its target price to $215 from $195 previously.
On December 07, 2023, Exane BNP Paribas started tracking the stock assigning a Outperform rating and target price of $237.Exane BNP Paribas initiated its Outperform rating on December 07, 2023, with a $237 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 11 ’24 when Reed Willie M sold 1,370 shares for $182.68 per share. The transaction valued at 250,265 led to the insider holds 9,994 shares of the business.
PECK KRISTIN C sold 13,000 shares of ZTS for $2,433,636 on Feb 20 ’24. The Chief Executive Officer now owns 79,366 shares after completing the transaction at $187.20 per share. On Feb 20 ’24, another insider, Lagano Roxanne, who serves as the Executive Vice President of the company, sold 923 shares for $187.30 each. As a result, the insider received 172,878 and left with 16,646 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ZTS now has a Market Capitalization of 80.69B and an Enterprise Value of 85.41B. As of this moment, Zoetis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 34.76, and their Forward P/E ratio for the next fiscal year is 27.18. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.57. For the stock, the TTM Price-to-Sale (P/S) ratio is 9.44 while its Price-to-Book (P/B) ratio in mrq is 16.17. Its current Enterprise Value per Revenue stands at 10.00 whereas that against EBITDA is 23.30.
Stock Price History:
Over the past 52 weeks, ZTS has reached a high of $201.92, while it has fallen to a 52-week low of $151.03. The 50-Day Moving Average of the stock is 191.12, while the 200-Day Moving Average is calculated to be 180.87.
Shares Statistics:
ZTS traded an average of 2.29M shares per day over the past three months and 4.02M shares per day over the past ten days. A total of 458.37M shares are outstanding, with a floating share count of 457.47M. Insiders hold about 0.09% of the company’s shares, while institutions hold 95.52% stake in the company. Shares short for ZTS as of Feb 29, 2024 were 3.77M with a Short Ratio of 1.65, compared to 2.96M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 0.82% and a Short% of Float of 0.82%.
Dividends & Splits
With its trailing 12-month dividend rate of 1.50, ZTS has a forward annual dividend rate of 1.56. Against a Trailing Annual Dividend Yield of 0.83%, it implies a Forward Annual Dividend Yield of 0.98%. The stock’s 5-year Average Dividend Yield is 0.62.
Earnings Estimates
The firm’s stock currently is rated by 10 analysts. On average, analysts expect EPS of $1.36 for the current quarter, with a high estimate of $1.45 and a low estimate of $1.3, while EPS last year was $1.31. The consensus estimate for the next quarter is $1.51, with high estimates of $1.58 and low estimates of $1.47.
Analysts are recommending an EPS of between $6.04 and $5.66 for the fiscal current year, implying an average EPS of $5.8. EPS for the following year is $6.48, with 16 analysts recommending between $6.99 and $6.17.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 8 analysts. It ranges from a high estimate of $2.28B to a low estimate of $2.11B. As of the current estimate, Zoetis Inc’s year-ago sales were $2.01B, an estimated increase of 7.70% from the year-ago figure. For the next quarter, 8 analysts are estimating revenue of $2.32B, an increase of 7.30% less than the figure of $7.70% in the same quarter last year. There is a high estimate of $2.35B for the next quarter, whereas the lowest estimate is $2.29B.
A total of 16 analysts have provided revenue estimates for ZTS’s current fiscal year. The highest revenue estimate was $9.33B, while the lowest revenue estimate was $9.13B, resulting in an average revenue estimate of $9.19B. In the same quarter a year ago, actual revenue was $8.54B, up 7.50% from the average estimate. Based on 16 analysts’ estimates, the company’s revenue will be $9.84B in the next fiscal year. The high estimate is $10.16B and the low estimate is $9.6B. The average revenue growth estimate for next year is up 7.10% from the average revenue estimate for this year.
